GSK and Bharat Biotech collaborate to reduce malaria vaccine price, enhance production, and supply to Gavi by 2028.

Rwanda has contributed $1million to Gavi, the global vaccine initiative, amid funding shortages caused by, among other factors, the dismantling of the United States Agency for International ...

HYDERABAD: Bharat Biotech International Limited (BBIL) and GSK plc on Wednesday announced a price reduction on the world’s ...

Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world's first malaria ...

Bharat Biotech and GSK will lower the malaria vaccine price to under $5 by 2028. This is due to better processes and more ...

Bharat Biotech International will start supplying world’s first malaria vaccine RTS.S, developed by global biopharma major GSK, to vaccine alliance Gavi from 2026.

The announcement comes amid deep cuts to global aid budgets, which threaten to reverse decades of progress in child survival ...

Bharat Biotech & GSK to slash malaria vaccine price by over 50% by 2028, aiming for increased access in Africa. A major step ...

Hyderabad: Bharat Biotech will be reducing the price of world's first malaria vaccine RTS.S, developed by GSK, PATH and ...

As part of a multi-year collaboration, GSK and India’s Bharat Biotech are redoubling their efforts to bring the world’s first malaria vaccine to more countries in need at affordable prices. | The ...

Bharat Biotech and GSK to reduce RTS,S malaria vaccine price to under $5 per dose by 2028, enhancing access for children in ...